Avatrombopag Explained
Verifiedfields: | changed |
Watchedfields: | changed |
Width: | 200 |
Pronounce: | a" va trom' boe pag |
Tradename: | Doptelet |
Dailymedid: | Avatrombopag |
Pregnancy Au: | B3 |
Routes Of Administration: | By mouth |
Atc Prefix: | B02 |
Atc Suffix: | BX08 |
Legal Au: | S4 |
Legal Au Comment: | [1] [2] [3] |
Legal Ca: | Rx-only |
Legal Ca Comment: | [4] [5] |
Legal Us: | Rx-only |
Legal Us Comment: | [6] |
Legal Eu: | Rx-only |
Legal Status: | Rx-only |
Index2 Label: | as salt |
Cas Number: | 570406-98-3 |
Pubchem: | 9852519 |
Drugbank: | DB11995 |
Chemspiderid: | 8028230 |
Unii: | 3H8GSZ4SQL |
Kegg: | D10306 |
Kegg2: | D10307 |
Chembl: | 2103883 |
Iupac Name: | 1-[3-Chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic acid |
C: | 29 |
H: | 34 |
Cl: | 2 |
N: | 6 |
O: | 3 |
S: | 2 |
Smiles: | C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl |
Stdinchi: | 1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38) |
Stdinchikey: | OFZJKCQENFPZBH-UHFFFAOYSA-N |
Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure.[7] [8] It was approved for medical use in the United States in May 2018,[9] [10] the European Union in June 2019,[11] and Australia in January 2023.
It acts as a thrombopoietin receptor agonist.[12]
Notes and References
- Web site: Doptelet . Therapeutic Goods Administration (TGA) . 30 January 2023 . 8 April 2023 . 5 February 2023 . https://web.archive.org/web/20230205203411/https://www.tga.gov.au/resources/auspmd/doptelet . live .
- Web site: Doptelet (Swedish Orphan Biovitrum Pty Ltd) . Therapeutic Goods Administration (TGA) . 16 February 2023 . 8 April 2023 . 27 March 2023 . https://web.archive.org/web/20230327062348/https://www.tga.gov.au/resources/prescription-medicines-registrations/doptelet-swedish-orphan-biovitrum-pty-ltd . live .
- Web site: AusPAR: Doptelet . Therapeutic Goods Administration (TGA) . 8 February 2024 . 31 March 2024.
- Web site: Details for: Doptelet . . 22 January 2024 . 3 March 2024 . 3 March 2024 . https://web.archive.org/web/20240303053753/https://dhpp.hpfb-dgpsa.ca/dhpp/resource/103124 . live .
- Web site: Summary Basis of Decision for Doptelet . . 17 May 2024 . 8 June 2024.
- Web site: Doptelet- avatrombopag maleate tablet, film coated . DailyMed . 1 July 2021 . 3 March 2024 . 3 March 2024 . https://web.archive.org/web/20240303053935/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2d5960d-6c18-46cc-86bd-089222b09852 . live .
- Abdela J . Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag . Clinical Medicine Insights. Blood Disorders . 12 . 1179545X19875105 . 2019 . 31673229 . 6804364 . 10.1177/1179545X19875105 .
- Markham A . Avatrombopag: A Review in Thrombocytopenia . Drugs . 81 . 16 . 1905–1913 . November 2021 . 34709601 . 8610948 . 10.1007/s40265-021-01613-y .
- FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure . U.S. Food and Drug Administration (FDA) . 21 May 2018 . 2 May 2020 . 11 December 2019 . https://web.archive.org/web/20191211204725/https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-patients-chronic-liver-disease-who-have-low-blood-platelets-and-are-undergoing . live .
- Web site: Drug Approval Package: Doptelet (avatrombopag) . U.S. Food and Drug Administration (FDA) . 28 June 2018 . 2 May 2020 . 7 April 2021 . https://web.archive.org/web/20210407143028/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210238Orig1s000TOC.cfm . live .
- Web site: Doptelet EPAR . European Medicines Agency (EMA) . 24 April 2019 . 2 May 2020 . 22 May 2020 . https://web.archive.org/web/20200522175116/https://www.ema.europa.eu/en/medicines/human/EPAR/doptelet . live .
- Kuter DJ . The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag . Blood Reviews . 53. 100909 . November 2021 . 34815110 . 10.1016/j.blre.2021.100909 . 244285488 . free .